Ipecac, an over-the-counter emetic agent, has been a drug of choice fo
r abuse by patients with eating disorders. Its alkaloid emetine has be
en associated with serious cardiac toxicity; however, the dose effect
has not been well established. We present a patient with anorexia and
bulimia nervosa who ingested ipecac chronically and developed the char
acteristic manifestations of ipecac toxicity. Unexpectedly, her induce
d left ventricular dysfunction returned to normal after only 10 days o
f withholding the drug. This finding, in contrast with the findings of
other reports, establishes that ipecac cardiomyopathy can be readily
reversible. The cumulative experience thus far, nonetheless, provides
no discernible pattern of the effect of ipecac on the myocardium. Thus
, in the continuum of poisoning, the point at which the myocardium bec
omes irreversibly damaged is undetermined. With continued abuse, poten
tially lethal outcome, and limited experience with ipecac cardiotoxici
ty, further investigation and perhaps heightened restriction of the dr
ug are warranted.